Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-2,921
Closed -$447K 17
2022
Q2
$447K Hold
2,921
0.33% 12
2022
Q1
$473K Buy
2,921
+343
+13% +$49.8K 0.53% 13
2021
Q4
$349K Sell
2,578
-3,071
-54% -$363K 0.26% 33
2021
Q3
$609K Sell
5,649
-1,065
-16% -$122K 0.41% 19
2021
Q2
$756K Hold
6,714
0.49% 17
2021
Q1
$727K Sell
6,714
-2,262
-25% -$242K 0.62% 15
2020
Q4
$962K Buy
+8,976
New +$863K 0.88% 13

Other funds holding ABBV

Mosaic Advisors's ABBV Position: Q3 2022 in Review

Mosaic Advisors sold out of AbbVie (ABBV) in Q3 2022, closing a stake of 2,921 shares — an estimated $447K sold.

Mosaic Advisors first reported a position in ABBV in Q4 2020 and held it in 7 quarters. The position peaked at $962K in Q4 2020. 2,969 funds tracked by Wall St. Rank hold ABBV as of Q3 2022.

  • Mosaic Advisors reported no remaining AbbVie position as of Q3 2022 after selling out during the quarter.
  • Mosaic Advisors sold 2,921 AbbVie shares in Q3 2022, an estimated $447K.
  • Mosaic Advisors first reported a position in AbbVie in Q4 2020 and held it in 7 quarters.
  • Mosaic Advisors's AbbVie position peaked at $962K in Q4 2020.
  • 2,969 funds tracked by Wall St. Rank held AbbVie as of Q3 2022.

Based on Mosaic Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.